1. Home
  2. MOVE vs ABCL Comparison

MOVE vs ABCL Comparison

Compare MOVE & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MOVE

Movano Inc.

HOLD

Current Price

$14.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$6.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOVE
ABCL
Founded
2018
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
MOVE
ABCL
Price
$14.70
$6.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.40
AVG Volume (30 Days)
45.5K
7.5M
Earning Date
04-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$433,000.00
$75,128,000.00
Revenue This Year
$1,460.71
N/A
Revenue Next Year
$96.77
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$0.52
$2.75
52 Week High
$34.87
$8.44

Technical Indicators

Market Signals
Indicator
MOVE
ABCL
Relative Strength Index (RSI) 38.07 52.21
Support Level $11.63 $3.38
Resistance Level $15.51 $8.44
Average True Range (ATR) 2.69 0.68
MACD -0.66 -0.14
Stochastic Oscillator 5.50 27.45

Price Performance

Historical Comparison
MOVE
ABCL

About MOVE Movano Inc.

Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: